On World TB Day, conversations often focus on awareness. However, one of the most critical challenges in tuberculosis (TB) control is delayed and inadequate diagnosis.…
Tag: drug resistance tuberculosis
Drug-resistant tuberculosis (DR-TB) is a major global health concern caused by Mycobacterium tuberculosis strains that develop resistance to anti-tuberculosis medications. Forms such as multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) require rapid and accurate diagnostic approaches to enable effective treatment decisions.
Modern molecular diagnostics, including real-time PCR and targeted next-generation sequencing (NGS), provide faster detection of resistance-associated mutations compared with conventional approaches. Advanced technologies can identify resistance against first-line, second-line, and newer anti-TB drugs, helping laboratories and clinicians make informed decisions. Genes2Me’s TB diagnostic solutions include RT-PCR assays, automated molecular platforms, and comprehensive NGS-based drug resistance profiling designed for accurate and efficient tuberculosis management